Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Hybridoma|April 22, 1999
Milestones in the development of Lym-1 therapyG L DeNardo, R T O'Donnell, L M Rose, et al.
Cancer|December 24, 1997
Imaging for improved prediction of myelotoxicity after radioimmunotherapyD A DeNardo, G L DeNardo, R T O'Donnell, et al.
Nuclear Medicine and Biology|July 1, 1997
Practical determination of organ S values for individual patients for therapyS Shen, G L DeNardo, D J Macey, et al.
Anticancer Research|March 28, 2001
A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphomaR T O'Donnell, S Shen, S J Denardo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Prediction of myelotoxicity using radiation doses to marrow from body, blood and marrow sourcesS M Lim, G L DeNardo, D A DeNardo, et al.
Journal of Molecular Biology|September 5, 1987
High-affinity L-arabinose transport operon. Nucleotide sequence and analysis of gene productsJ B Scripture, C Voelker, S Miller, et al.
The Prostate|July 25, 2000
Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored miceR T O'Donnell, S J DeNardo, G L DeNardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Strategies for developing effective radioimmunotherapy for solid tumorsG L DeNardo, R T O'Donnell, L A Kroger, et al.
Pageof 11